Saturday 17 October 2026 Export LFST’s income statement to Excel — free account

LifeStance Health Group, Inc.

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 26.1%, EPS grew 700.0%, free cash flow grew 55.2% and total debt fell 5.08%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

11.74 0.63 −5.09%

Follow LFST

Alert me

Market cap: $4.7B
P/E: 88.3×
Fwd P/E: 58.5×
Dividend yield: —
F-score: 8/9
Altman Z: 2.65
Beneish M: −2.96
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 847.23

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	4	—	—	2	2	5	1	—	6	2	—

Insider Ownership 31.91%

Capital & Financial Ratios $m

Market Cap 4,730.00

Revenue 1,584.83

Net Income 50.60

Free Cash Flow 173.91

Net Debt 33.05

Current Ratio 1.38

Debt/Equity 0.18

P/E ratio 88.27

Fwd P/E 58.50

P/S ratio 2.84

P/B ratio 3.05

Past 5Y EPS Growth —

This Y EPS Growth 702.67%

Next Y EPS Growth 36.68%

Next Y revenue growth 19.99%

Next 5Y EPS Growth 180.50%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 62.97%

10-year low 10-year high

P/B against its own 10 years 92.04%

10-year low 10-year high

EV/Sales against its own 10 years 60.97%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	79	155	249	226
Receivables	125	132	96	111
Inventory	—	—	—	—
Other	—	—	—	—
	226	313	416	378

	2023	2024	2025	Q'26
Payables	7	7	6	11
ST’ Debt	—	—	—	—
Other	12	8	15	18
	203	229	252	275

Compound Annual Growth %

	10y	5y	3y
Sales	—	30.44%	18.33%
Cash Flow	—	0.00%	40.42%
Earnings	—	0.00%	0.00%
Book Value	—	8.80%	0.05%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	403	435	—	—	—
’25	333	345	364	382	1,424
’24	300	312	313	325	1,251
’23	253	260	263	281	1,056
’22	203	210	218	229	860
’21	143	161	174	190	668
’20	73	84	102	118	377

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	33	100	—	—	—
’25	(3)	64	27	58	146
’24	(22)	44	23	62	107
’23	(8)	0	(25)	17	(17)
’22	3	8	6	36	53
’21	10	(17)	(14)	31	9
’20	2	(26)	11	(9)	(9)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	22	88	—	—	—
’25	(10)	57	17	47	110
’24	(27)	39	18	56	86
’23	(16)	(12)	(35)	5	(57)
’22	(25)	(18)	(9)	26	(26)
’21	(1)	(38)	(38)	(8)	(85)
’20	(6)	(36)	2	(7)	(47)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.04	0.06	—	—	—
’25	0.00	(0.01)	0.00	0.03	0.02
’24	(0.06)	(0.06)	(0.02)	(0.02)	(0.15)
’23	(0.09)	(0.13)	(0.17)	(0.12)	(0.51)
’22	(0.18)	(0.19)	(0.11)	(0.13)	(0.61)
’21	(0.03)	(0.22)	(0.35)	(0.32)	(1.05)
’20	—	(0.11)	(0.01)	(0.01)	(0.13)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	7.64	4.22	4.35	4.64	3.74	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	29.81	11.25	9.59	9.20	8.30
People
People	Employees	—	—	—	—	2,674	4,790	7,830	9,325	10,218	10,961
	Revenue/emp, $m	—	—	—	0.00	0.14	0.14	0.11	0.11	0.12	0.13
Income, $m
Income, $m	Revenue	—	—	—	213	377	668	860	1,056	1,251	1,424
	Gross margin, %	—	—	—	29.36	31.59	30.19	27.57	28.62	32.17	32.37
	EBT	—	—	—	8	(44)	(333)	(233)	(207)	(58)	12
	EBT margin, %	—	—	—	3.71	(11.77)	(49.90)	(27.08)	(19.57)	(4.61)	0.87
	Net income	—	0	—	6	(38)	(307)	(216)	(186)	(57)	10
	Depreciation	—	—	—	7	32	56	71	83	73	56
Per share, $
Per share, $	Revenue	—	—	—	0.57	1.25	2.04	2.42	2.87	3.30	3.69
	Earnings	—	—	—	(0.16)	(0.13)	(1.05)	(0.61)	(0.51)	(0.15)	0.03
	Cash flow	—	—	—	0.05	(0.03)	0.03	0.15	(0.05)	0.28	0.38
	Capex	—	—	—	(0.04)	(0.13)	(0.29)	(0.22)	(0.11)	(0.06)	(0.09)
	Free cash flow	—	—	—	0.01	(0.15)	(0.26)	(0.07)	(0.16)	0.23	0.29
	Book value	—	—	—	(0.45)	3.30	4.72	4.27	3.89	3.81	3.94
	Shares, m	—	—	—	374	302	328	355	367	379	386
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	283.87
	P/S	—	—	—	14.96	14.96	4.67	1.92	2.75	2.23	1.91
	P/B	—	—	—	7.01	7.01	2.02	1.09	2.03	1.93	1.79
	EV/Sales	—	—	—	15.74	15.74	4.69	2.06	2.94	2.33	1.92
	EV/FCF	—	—	—	(166.98)	(166.98)	(36.76)	(66.82)	(54.08)	34.07	24.86
Cash, $m
Cash, $m	Operating cash flow	—	—	—	17	(9)	9	53	(17)	107	146
	Capex	—	—	—	(14)	(38)	(94)	(79)	(41)	(22)	(36)
	Free cash flow	—	—	—	3	(47)	(85)	(26)	(57)	86	110
Balance, $m
Balance, $m	Working capital	—	—	—	(28)	0	150	57	23	84	164
	Total debt	—	—	—	79	363	157	225	280	280	266
	Net debt	—	—	—	76	344	9	116	201	125	17
	Shareholders’ equity	—	—	—	(166)	998	1,545	1,519	1,429	1,446	1,521
Returns, %
Returns, %	ROA	—	—	—	(41.96)	(33.65)	(19.67)	(10.51)	(8.70)	(2.72)	0.45
	ROIC	—	—	—	0.00	0.72	(11.51)	(8.03)	(7.25)	(1.26)	0.98
	ROE	—	—	—	(14.16)	(74.88)	(27.05)	(14.07)	(12.64)	(4.00)	0.65

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%	Compare
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%	Compare
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
LFST LifeStance Health Group, Inc.	$4.7B	88.3×	58.5×	+26.08% (above 0%: growing)	n/m	+55.22% (above 0%: growing)	35.15%	7.04%
OPCH Option Care Health, Inc.	$4.7B	23.5×	14.1×	+1.86% (above 0%: growing)	+12.90% (above 0%: growing)	+112.36% (above 0%: growing)	18.53%	5.90%	Compare
NHC National HealthCare Corporation	$3.9B	26.9×	8.4×	+8.83% (above 0%: growing)	+68.63% (above 0%: growing)	−41.57% (below 0%: shrinking)	100.00%	11.99%	Compare
ACHC Acadia Healthcare Company, Inc.	$2.9B	— (loss-making)	21.1×	−0.39% (below 0%: shrinking)	−63.64% (below 0%: shrinking)	+856.54% (above 0%: growing)	100.00%	10.14%	Compare
AVAH Aveanna Healthcare Holdings Inc.	$2.8B	9.5×	10.4×	+13.73% (above 0%: growing)	+46.15% (above 0%: growing)	+57.89% (above 0%: growing)	32.59%	11.93%	Compare
GRDN Guardian Pharmacy Services, Inc.	$2.5B	37.5×	39.5×	+2.16% (above 0%: growing)	+133.33% (above 0%: growing)	+60.83% (above 0%: growing)	22.75%	5.87%	Compare
Median of peers	$4.3B	25.7×	16.9×	+8.82%	+45.58%	+76.23%	32.15%	11.04%

All 55 Medical Care Facilities stocks →

LifeStance Health Group, Inc. (LFST) key facts

Strength: LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
LifeStance Health Group, Inc. (LFST) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, LFST traded at $11.74, a market capitalization of $4.7 billion.
Return on equity was 0.65% and debt-to-equity 0.18.
Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 2.65 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.